Home/Filings/4/0001127602-21-014776
4//SEC Filing

SAGAN PAUL 4

Accession 0001127602-21-014776

CIK 0001682852other

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 4:13 PM ET

Size

11.3 KB

Accession

0001127602-21-014776

Insider Transaction Report

Form 4
Period: 2021-04-28
SAGAN PAUL
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-04-28+4,0814,081 total
    Exercise: $178.68Exp: 2031-04-28Common Stock (4,081 underlying)
  • Award

    Restricted Stock Units

    2021-04-28+703703 total
    Exercise: $0.00Common Stock (703 underlying)
Footnotes (2)
  • [F1]This option will become fully vested and exercisable on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
  • [F2]The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Issuer

Moderna, Inc.

CIK 0001682852

Entity typeother

Related Parties

1
  • filerCIK 0001035440

Filing Metadata

Form type
4
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 4:13 PM ET
Size
11.3 KB